CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$bgne #beigene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that the Company will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 9:50 a.m. ET.
A live webcast can be accessed from the investors section of BeiGene�s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of over 8,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor Contact
Kevin Mannix
+1 857-302-5189
ir@beigene.com
Media Contact
Liza Heapes
+1 857-302-5663
media@beigene.com
HONG KONG SAR - Media OutReach Newswire - 18 December 2025 - Another international law-related…
HAIKOU, CHINA - Media OutReach Newswire - 18 December 2025 - China on Thursday launched…
HAIKOU, CHINA - Media OutReach Newswire - 18 December 2025 - The 28th China (Hainan)…
HONG KONG SAR - Media OutReach Newswire - 18 December 2025 - Hongkong Land is…
A rare exhibition tracing an eight-year cross-cultural art journey between rural Yunnan and Singapore, showing…
Celebrating 26 Visionary Leadership in Sustainability HONG KONG SAR - Media OutReach Newswire - 18…